Sign in
In elderly patients with AML, which patients should be considered fit or unfit for standard induction therapy?
Journal article

In elderly patients with AML, which patients should be considered fit or unfit for standard induction therapy?

Ronan Swords and Valeria Santini
Hematology, Vol.2012(1), pp.74-75
2012
PMID: 23233563

Abstract

Age Factors Aged Aging Comorbidity Hematology - methods Humans Hypertension - complications Leukemia, Myeloid, Acute - therapy Male Medical Oncology - methods Neoadjuvant Therapy - methods Remission Induction Retrospective Studies Risk Treatment Outcome

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.103 Blood Disorders
1.103.155 Acute Myeloid Leukemia
Web Of Science research areas
Education, Scientific Disciplines
Hematology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details